127 related articles for article (PubMed ID: 35279593)
1. Establishment of a human induced pluripotent stem cell line, KMUGMCi001-A, from a patient bearing a heterozygous c.772 + 3_772 + 4dup mutation in the ACVRL1 gene leading Telangiectasia, hereditary hemorrhagic, type 2 (HHT2).
Ura H; Togi S; Iwata Y; Ozaki M; Niida Y
Stem Cell Res; 2022 May; 61():102743. PubMed ID: 35279593
[TBL] [Abstract][Full Text] [Related]
2. Generation and genetic repair of 2 iPSC clones from a patient bearing a heterozygous c.1120del18 mutation in the ACVRL1 gene leading to Hereditary Hemorrhagic Telangiectasia (HHT) type 2.
Bouma MJ; Orlova V; van den Hil FE; Mager HJ; Baas F; de Knijff P; Mummery CL; Mikkers H; Freund C
Stem Cell Res; 2020 Jul; 46():101786. PubMed ID: 32485642
[TBL] [Abstract][Full Text] [Related]
3. Generation of a Syngeneic Heterozygous
Xiang-Tischhauser L; Bette M; Rusche JR; Roth K; Kasahara N; Stuck BA; Bakowsky U; Wartenberg M; Sauer H; Geisthoff UW; Mandic R
Cells; 2023 Jun; 12(12):. PubMed ID: 37371070
[TBL] [Abstract][Full Text] [Related]
4. An intron mutation in the ACVRL1 may be associated with a transcriptional regulation defect in a Chinese family with hereditary hemorrhagic telangiectasia.
Yu Q; Shen XH; Li Y; Li RJ; Li J; Luo YY; Liu SF; Deng MY; Pei MF; Zhang GS
PLoS One; 2013; 8(2):e58031. PubMed ID: 23460919
[TBL] [Abstract][Full Text] [Related]
5. [Mutations of ACVRL1 gene in a pedigree with hereditary hemorrhagic telangiectasia].
Luo JW; Chen H; Yang LQ; Zhu AL; Wu YA; Li JW
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):308-10. PubMed ID: 18543223
[TBL] [Abstract][Full Text] [Related]
6. Functional and splicing defect analysis of 23 ACVRL1 mutations in a cohort of patients affected by Hereditary Hemorrhagic Telangiectasia.
Alaa El Din F; Patri S; Thoreau V; Rodriguez-Ballesteros M; Hamade E; Bailly S; Gilbert-Dussardier B; Abou Merhi R; Kitzis A
PLoS One; 2015; 10(7):e0132111. PubMed ID: 26176610
[TBL] [Abstract][Full Text] [Related]
7. Heart failure and pulmonary arteriovenous malformations in a patient with hereditary hemorrhagic telangiectasia type 2.
Du J; Zhu Y; Zhang YL; Li S; Huang J; Luo XH; Liu L
J Thromb Thrombolysis; 2015 Nov; 40(4):515-9. PubMed ID: 26245826
[TBL] [Abstract][Full Text] [Related]
8. Decreased Expression of Vascular Endothelial Growth Factor Receptor 1 Contributes to the Pathogenesis of Hereditary Hemorrhagic Telangiectasia Type 2.
Thalgott JH; Dos-Santos-Luis D; Hosman AE; Martin S; Lamandé N; Bracquart D; Srun S; Galaris G; de Boer HC; Tual-Chalot S; Kroon S; Arthur HM; Cao Y; Snijder RJ; Disch F; Mager JJ; Rabelink TJ; Mummery CL; Raymond K; Lebrin F
Circulation; 2018 Dec; 138(23):2698-2712. PubMed ID: 30571259
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis in Norwegian families with hereditary hemorrhagic telangiectasia: founder mutations in ACVRL1.
Heimdal K; Dalhus B; Rødningen OK; Kroken M; Eiklid K; Dheyauldeen S; Røysland T; Andersen R; Kulseth MA
Clin Genet; 2016 Feb; 89(2):182-6. PubMed ID: 25970827
[TBL] [Abstract][Full Text] [Related]
10. Genotype-phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French-Italian HHT network.
Lesca G; Olivieri C; Burnichon N; Pagella F; Carette MF; Gilbert-Dussardier B; Goizet C; Roume J; Rabilloud M; Saurin JC; Cottin V; Honnorat J; Coulet F; Giraud S; Calender A; Danesino C; Buscarini E; Plauchu H;
Genet Med; 2007 Jan; 9(1):14-22. PubMed ID: 17224686
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital.
Karlsson T; Cherif H
Ups J Med Sci; 2018 Sep; 123(3):153-157. PubMed ID: 30251589
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of the BMP9 response of ALK1 mutants from HHT2 patients: a diagnostic tool for novel ACVRL1 mutations.
Ricard N; Bidart M; Mallet C; Lesca G; Giraud S; Prudent R; Feige JJ; Bailly S
Blood; 2010 Sep; 116(9):1604-12. PubMed ID: 20501893
[TBL] [Abstract][Full Text] [Related]
13. A case report of isolated right ventricular noncompaction with mutation of ACVRL1: a new cause of noncompaction of ventricular myocardium?
Yu B; Shi K; Wen Y; Yang Y
BMC Cardiovasc Disord; 2023 Apr; 23(1):224. PubMed ID: 37120586
[TBL] [Abstract][Full Text] [Related]
14. Sequence variations of ACVRL1 play a critical role in hepatic vascular malformations in hereditary hemorrhagic telangiectasia.
Giraud S; Bardel C; Dupuis-Girod S; Carette MF; Gilbert-Dussardier B; Riviere S; Saurin JC; Eyries M; Patri S; Decullier E; Calender A; Lesca G
Orphanet J Rare Dis; 2020 Sep; 15(1):254. PubMed ID: 32962750
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive CT screening for pulmonary arteriovenous malformations in children with confirmed hereditary hemorrhagic telangiectasia: Results from two pediatric centers.
Soysal N; Eyries M; Verlhac S; Escabasse V; Remus N; Tamalet A; Rioux JY; Franchi-Abella S; Vasile M; Robert S; Delestrain C; Hau I; Ducou-Le Pointe H; Soubrier F; Carette MF; Epaud R
Pediatr Pulmonol; 2017 May; 52(5):642-649. PubMed ID: 28165669
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary Hypertension and Hereditary Hemorrhagic Telangiectasia Related to an ACVRL1 Mutation.
Yokokawa T; Sugimoto K; Kimishima Y; Misaka T; Yoshihisa A; Morisaki H; Yamada O; Nakazato K; Ishida T; Takeishi Y
Intern Med; 2020 Jan; 59(2):221-227. PubMed ID: 31511490
[TBL] [Abstract][Full Text] [Related]
17. [Hereditary hemorrhagic telangiectasia. Report of a pediatric case].
Maaloul I; Aloulou H; Fourati H; Sfaihi L; Chabchoub I; Kamoun T; Mnif Z; Hachicha M
Arch Pediatr; 2014 Jul; 21(7):768-71. PubMed ID: 24935454
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary arterial hypertension in hereditary hemorrhagic telangiectasia associated with ACVRL1 mutation: a case report.
Walsh LJ; Collins C; Ibrahim H; Kerins DM; Brady AP; O Connor TM
J Med Case Rep; 2022 Mar; 16(1):99. PubMed ID: 35232468
[TBL] [Abstract][Full Text] [Related]
19. The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations.
Pawlikowska L; Nelson J; Guo DE; McCulloch CE; Lawton MT; Young WL; Kim H; Faughnan ME;
Am J Med Genet A; 2015 Jun; 167(6):1262-7. PubMed ID: 25847705
[TBL] [Abstract][Full Text] [Related]
20. Genotype-phenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations.
Bayrak-Toydemir P; McDonald J; Markewitz B; Lewin S; Miller F; Chou LS; Gedge F; Tang W; Coon H; Mao R
Am J Med Genet A; 2006 Mar; 140(5):463-70. PubMed ID: 16470787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
